Soluble PD-1 and SPD-L2 are unaffected by Adalimumab treatment in early RA and associated with resence of anti-CCP and IgM-RF

Stinne Ravn Greisen, Kristian Stengaard-Pedersen, Merete Lund Hetland, Kim Hørslev-Petersen, Bent Winding Deleuran

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdatojun. 2013
StatusUdgivet - jun. 2013
BegivenhedEULAR 2013 Madrid: European Congress of Rheumatology - Madrid, Spanien
Varighed: 12. jun. 201315. jun. 2013

Konference

KonferenceEULAR 2013 Madrid
LandSpanien
ByMadrid
Periode12/06/201315/06/2013

Citer dette

Greisen, S. R., Stengaard-Pedersen, K., Hetland, M. L., Hørslev-Petersen, K., & Deleuran, B. W. (2013). Soluble PD-1 and SPD-L2 are unaffected by Adalimumab treatment in early RA and associated with resence of anti-CCP and IgM-RF. Abstract fra EULAR 2013 Madrid, Madrid, Spanien.
Greisen, Stinne Ravn ; Stengaard-Pedersen, Kristian ; Hetland, Merete Lund ; Hørslev-Petersen, Kim ; Deleuran, Bent Winding. / Soluble PD-1 and SPD-L2 are unaffected by Adalimumab treatment in early RA and associated with resence of anti-CCP and IgM-RF. Abstract fra EULAR 2013 Madrid, Madrid, Spanien.
@conference{28765163c8f54176a857b5707f3b06fa,
title = "Soluble PD-1 and SPD-L2 are unaffected by Adalimumab treatment in early RA and associated with resence of anti-CCP and IgM-RF",
author = "Greisen, {Stinne Ravn} and Kristian Stengaard-Pedersen and Hetland, {Merete Lund} and Kim H{\o}rslev-Petersen and Deleuran, {Bent Winding}",
year = "2013",
month = "6",
language = "English",
note = "null ; Conference date: 12-06-2013 Through 15-06-2013",

}

Greisen, SR, Stengaard-Pedersen, K, Hetland, ML, Hørslev-Petersen, K & Deleuran, BW 2013, 'Soluble PD-1 and SPD-L2 are unaffected by Adalimumab treatment in early RA and associated with resence of anti-CCP and IgM-RF' EULAR 2013 Madrid, Madrid, Spanien, 12/06/2013 - 15/06/2013, .

Soluble PD-1 and SPD-L2 are unaffected by Adalimumab treatment in early RA and associated with resence of anti-CCP and IgM-RF. / Greisen, Stinne Ravn; Stengaard-Pedersen, Kristian; Hetland, Merete Lund; Hørslev-Petersen, Kim; Deleuran, Bent Winding.

2013. Abstract fra EULAR 2013 Madrid, Madrid, Spanien.

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

TY - ABST

T1 - Soluble PD-1 and SPD-L2 are unaffected by Adalimumab treatment in early RA and associated with resence of anti-CCP and IgM-RF

AU - Greisen, Stinne Ravn

AU - Stengaard-Pedersen, Kristian

AU - Hetland, Merete Lund

AU - Hørslev-Petersen, Kim

AU - Deleuran, Bent Winding

PY - 2013/6

Y1 - 2013/6

M3 - Conference abstract for conference

ER -

Greisen SR, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Deleuran BW. Soluble PD-1 and SPD-L2 are unaffected by Adalimumab treatment in early RA and associated with resence of anti-CCP and IgM-RF. 2013. Abstract fra EULAR 2013 Madrid, Madrid, Spanien.